Yu–Ming Chang

852 total citations
17 papers, 614 citations indexed

About

Yu–Ming Chang is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Surgery. According to data from OpenAlex, Yu–Ming Chang has authored 17 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Nephrology and 4 papers in Surgery. Recurrent topics in Yu–Ming Chang's work include Blood Pressure and Hypertension Studies (6 papers), Heart Rate Variability and Autonomic Control (6 papers) and Parathyroid Disorders and Treatments (2 papers). Yu–Ming Chang is often cited by papers focused on Blood Pressure and Hypertension Studies (6 papers), Heart Rate Variability and Autonomic Control (6 papers) and Parathyroid Disorders and Treatments (2 papers). Yu–Ming Chang collaborates with scholars based in Taiwan, United States and Indonesia. Yu–Ming Chang's co-authors include Vincent B. Young, Kuei‐Sen Hsu, John Y. Kao, Chih‐Hao Yang, Chiung‐Chun Huang, Chih‐Chung Shiao, Krishna Rao, Casey M. Theriot, Anna M. Seekatz and Alison Freeman and has published in prestigious journals such as Gastroenterology, PLoS ONE and Scientific Reports.

In The Last Decade

Yu–Ming Chang

15 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu–Ming Chang Taiwan 10 234 149 122 96 82 17 614
Beatriz Orozco Venezuela 18 105 0.4× 103 0.7× 49 0.4× 58 0.6× 36 0.4× 43 767
Christine Schuett Germany 12 140 0.6× 242 1.6× 19 0.2× 62 0.6× 15 0.2× 14 718
André Colom France 14 686 2.9× 67 0.4× 147 1.2× 41 0.4× 16 0.2× 20 1.4k
Ines Schwetz Austria 9 70 0.3× 135 0.9× 37 0.3× 71 0.7× 19 0.2× 14 551
F Izbéki Hungary 17 171 0.7× 19 0.1× 31 0.3× 78 0.8× 14 0.2× 39 930
Natalie Moll Germany 9 483 2.1× 90 0.6× 87 0.7× 13 0.1× 6 0.1× 12 820
Chunhui Bao China 20 240 1.0× 55 0.4× 16 0.1× 53 0.6× 106 1.3× 51 919
Martha Douglas‐Escobar United States 12 397 1.7× 10 0.1× 63 0.5× 15 0.2× 40 0.5× 18 1.3k
Diogo Dominguini Brazil 18 248 1.1× 86 0.6× 25 0.2× 28 0.3× 17 0.2× 46 924
William Roth United States 11 254 1.1× 25 0.2× 81 0.7× 11 0.1× 11 0.1× 25 717

Countries citing papers authored by Yu–Ming Chang

Since Specialization
Citations

This map shows the geographic impact of Yu–Ming Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu–Ming Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu–Ming Chang more than expected).

Fields of papers citing papers by Yu–Ming Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu–Ming Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu–Ming Chang. The network helps show where Yu–Ming Chang may publish in the future.

Co-authorship network of co-authors of Yu–Ming Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Yu–Ming Chang. A scholar is included among the top collaborators of Yu–Ming Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu–Ming Chang. Yu–Ming Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Kan, Wei‐Chih, et al.. (2024). Secondary hyperparathyroidism in chronic kidney disease: A narrative review focus on therapeutic strategy. Clinical Medicine. 24(5). 100238–100238. 3 indexed citations
3.
4.
Chang, Yu–Ming, et al.. (2022). Sepsis and Acute Kidney Injury: A Review Focusing on the Bidirectional Interplay. International Journal of Molecular Sciences. 23(16). 9159–9159. 60 indexed citations
5.
Su, Yu-Hsiang, et al.. (2021). A study of correlations between metabolic syndrome factors and osteosarcopenic adiposity. BMC Endocrine Disorders. 21(1). 216–216. 7 indexed citations
6.
Chang, Yu–Ming, et al.. (2020). Heart rate variability as an independent predictor for 8-year mortality among chronic hemodialysis patients. Scientific Reports. 10(1). 881–881. 25 indexed citations
7.
Wu, Eric, et al.. (2019). The Association between Nutritional Markers and Heart Rate Variability Indices in Patients Undergoing Chronic Hemodialysis. Journal of Clinical Medicine. 8(10). 1700–1700. 4 indexed citations
8.
Seekatz, Anna M., Casey M. Theriot, Krishna Rao, et al.. (2018). Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection. Anaerobe. 53. 64–73. 138 indexed citations
9.
Huang, Ya-Ting, et al.. (2017). Heart rate variability during hemodialysis is an indicator for long-term vascular access survival in uremic patients. PLoS ONE. 12(3). e0172212–e0172212. 8 indexed citations
10.
Chang, Yu–Ming, et al.. (2016). Impact of metabolic syndrome and its components on heart rate variability during hemodialysis: a cross-sectional study. Cardiovascular Diabetology. 15(1). 16–16. 15 indexed citations
11.
Chang, Yu–Ming, et al.. (2016). Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients. Clinical and Experimental Nephrology. 21(5). 908–916. 22 indexed citations
12.
Chang, Yu–Ming, et al.. (2015). Heart rate variability is an indicator for intradialytic hypotension among chronic hemodialysis patients. Clinical and Experimental Nephrology. 20(4). 650–659. 24 indexed citations
13.
Sun, Yundong, Min Zhang, Chun‐Chia Chen, et al.. (2013). Stress-Induced Corticotropin-Releasing Hormone-Mediated NLRP6 Inflammasome Inhibition and Transmissible Enteritis in Mice. Gastroenterology. 144(7). 1478–1487.e8. 119 indexed citations
14.
Chang, Yu–Ming, et al.. (2010). The Case | A woman with severe metabolic acidosis. Kidney International. 77(3). 261–262. 3 indexed citations
15.
Chang, Yu–Ming, et al.. (2009). Estrogen modulates sexually dimorphic contextual fear extinction in rats through estrogen receptor β. Hippocampus. 19(11). 1142–1150. 165 indexed citations
16.
Pearn, W. L., Yu–Ming Chang, & Chien‐Wei Wu. (2004). Distributional and Inferential Properties of the Process Loss Indices. Journal of Applied Statistics. 31(9). 1115–1135. 11 indexed citations
17.
Chang, Yu–Ming, et al.. (1965). HEXACHLOROPARAXYLOL IN TREATMENT OF CLONORCHIASIS SINENSIS IN ANIMALS AND MAN.. PubMed. 84. 232–47. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beatriz Orozco Breakdown of academic impact, for papers by Christine Schuett Breakdown of academic impact, for papers by André Colom Breakdown of academic impact, for papers by Ines Schwetz Breakdown of academic impact, for papers by F Izbéki Breakdown of academic impact, for papers by Natalie Moll Breakdown of academic impact, for papers by Chunhui Bao Breakdown of academic impact, for papers by Martha Douglas‐Escobar Breakdown of academic impact, for papers by Diogo Dominguini Breakdown of academic impact, for papers by William Roth
Rankless by CCL
2026